MSB 7.69% $1.19 mesoblast limited

2024 Here we go again., page-346

  1. 4,169 Posts.
    lightbulb Created with Sketch. 5429
    I think we might hear about CIBMTR moving along with the adult trial shortly. The outcome of the discussion with FDA is as good as it can be, which bodes well for an adult trial that presumably is based off the same assays and clinical evidence that was just shown to FDA.

    Exciting times indeed.

    Hopefully within the next 3 months we get:
    Adult GvHD start recruiting,
    CLBP start recruiting,
    MSB resubmit BLA,




 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.